Stillwater Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,230
Closed -$214K 72
2017
Q4
$214K Hold
1,230
0.05% 70
2017
Q3
$229K Hold
1,230
0.06% 68
2017
Q2
$212K Hold
1,230
0.05% 76
2017
Q1
$202K Buy
+1,230
New +$204K 0.05% 75
2016
Q4
Sell
-1,215
Closed -$203K 75
2016
Q3
$203K Buy
+1,215
New +$205K 0.06% 73

Other funds holding AMGN

Stillwater Capital Advisors's AMGN Position: Q1 2018 in Review

Stillwater Capital Advisors sold out of Amgen (AMGN) in Q1 2018, closing a stake of 1,230 shares — an estimated $214K sold.

Stillwater Capital Advisors first reported a position in AMGN in Q3 2016 and held it in 5 quarters. The position peaked at $229K in Q3 2017. 1,749 funds tracked by Wall St. Rank hold AMGN as of Q1 2018.

  • Stillwater Capital Advisors reported no remaining Amgen position as of Q1 2018 after selling out during the quarter.
  • Stillwater Capital Advisors sold 1,230 Amgen shares in Q1 2018, an estimated $214K.
  • Stillwater Capital Advisors first reported a position in Amgen in Q3 2016 and held it in 5 quarters.
  • Stillwater Capital Advisors's Amgen position peaked at $229K in Q3 2017.
  • 1,749 funds tracked by Wall St. Rank held Amgen as of Q1 2018.

Based on Stillwater Capital Advisors's 13F filing for Q1 2018, filed 18 Apr 2018.